Early angioplasty in acute coronary syndromes without persistent ST-segment elevation improves outcome but increases the need for six-month repeat revascularization: An analysis of the PURSUIT trial

Journal of the American College of Cardiology

Volumn 39, Issue 12, 2002, Pages 1924-1929

  Ronner, Eelko ^a,b   Boersma, Eric ^a   Laarman, Gert Jan ^b   Somsen, G Aernout ^c   Harrington, Robert A ^d   Deckers, Jaap W ^a   Topol, Eric J ^e   Califf, Robert M ^d   Simoons, Maarten L ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b ONZE LIEVE VROUWE GASTHUIS   (Netherlands)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

^d DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^e LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CREATINE KINASE MB; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; EPTIFIBATIDE; FIBRINOGEN RECEPTOR ANTAGONIST; NITRATE;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CORONARY ARTERY DISEASE; FEMALE; HEART MUSCLE REVASCULARIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

AGED; ANGINA, UNSTABLE; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; RANDOMIZED CONTROLLED TRIALS; RETROSPECTIVE STUDIES; RISK FACTORS; SYNDROME; TREATMENT OUTCOME;

EID: 0037134835     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(02)01897-1     Document Type: Article

References (23)

1. Management of acute coronary syndromes: Acute coronary syndromes without persistent ST-segment elevation: Recommendations of the Task Force of the European Society of Cardiology
2. ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: Executive summary and recommendations: A report of the ACC/AHA Task Force on Practice Guidelines
3. Outcome at 1 year after an invasive compared with a non-invasive strategy in unstable coronary-artery disease: The Fast Revascularisation during InStability in Coronary artery disease (FRISC II) invasive randomised trial
4. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa receptor inhibitor tirofiban
5. Coronary angioplasty for unstable angina: Immediate and late results in 200 consecutive patients with identification of risk factors for unfavorable early and late outcomes
6. Morphologic changes during follow-up after successful percutaneous transluminal coronary balloon angioplasty: Quantitative angiographic analysis in 778 lesions - Further evidence for the restenosis paradox
7. Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes
8. Intravascular ultrasound predictors of restenosis after percutaneous transcatheter coronary revascularization
9. Comparison of immediate and long-term outcomes of coronary angioplasty performed for unstable angina and rest pain in men and women
10. Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation: Results from an international trial of 9,461 patients
11. Early percutaneous coronary intervention, platelet inhibition with eptifibatide, and clinical outcomes in patients with acute coronary syndromes
12. Patients with acute coronary syndromes without persistent ST-elevation undergoing percutaneous coronary intervention benefit most of early intervention with protection by a glycoprotein IIb/IIIa receptor blocker
13. Angiographic and clinical predictors of acute closure after native vessel coronary angioplasty
14. Subacute stent thrombosis: Evolving issues and current concepts
15. Randomized, placebo-controlled trial of platelet glycoprotein IIb/IIIa blockade with primary angioplasty for acute myocardial infarction
16. Enhanced inflammatory response to coronary angioplasty in patients with severe unstable angina
17. The prognostic value of C-reactive protein and serum amyloid, a protein in severe unstable angina
18. Prognostic influence of increased fibrinogen and C-reactive protein levels in unstable coronary artery disease
19. Elevated levels of C-reactive protein at discharge in patients with unstable angina predict recurrent instability
20. Predictive value of C-reactive protein and troponin T in patients with unstable angina: A comparative analysis
21. Instability of coronary lesions in unstable angina assessed by C-reactive protein values following coronary interventions
22. Early percutaneous coronary intervention, platelet inhibition with eptifibatide, and clinical outcomes in patients with acute coronary syndromes
23. Results of coronary stenting for unstable versus stable angina pectoris